000 | 01490 a2200433 4500 | ||
---|---|---|---|
005 | 20250513081715.0 | ||
264 | 0 | _c19930525 | |
008 | 199305s 0 0 eng d | ||
022 | _a0270-9139 | ||
024 | 7 |
_a10.1002/hep.1840170408 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPoupon, R E | |
245 | 0 | 0 |
_aCholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cApr 1993 |
||
300 |
_a577-82 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBile Acids and Salts _xblood |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 |
_aCholesterol, HDL _xblood |
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Cirrhosis, Biliary _xblood |
650 | 0 | 4 | _aLiver Function Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUrsodeoxycholic Acid _xtherapeutic use |
700 | 1 | _aOuguerram, K | |
700 | 1 | _aChrétien, Y | |
700 | 1 | _aVerneau, C | |
700 | 1 | _aEschwège, E | |
700 | 1 | _aMagot, T | |
700 | 1 | _aPoupon, R | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 17 _gno. 4 _gp. 577-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.1840170408 _zAvailable from publisher's website |
999 |
_c8477232 _d8477232 |